Inventors:
Patricia Grasso - Newtown CT, US
Matthew C. Leinung - Albany NY, US
International Classification:
A61K 38/08, A61P 3/10, A61P 35/00, A61P 19/00, A61P 31/06, A61P 31/18, A61P 1/12
US Classification:
514 24, 514 167, 514 217, 514 193, 514 69, 514 169, 514 41
Abstract:
The present invention relates to methods of increasing bone formation in patient suffering from a wasting disorder by orally or intranasally administering a pharmaceutically effective amount of a leptin peptide and a pharmaceutically acceptable carrier, wherein the leptin peptide increases serum osteocalcin levels.